Journal of molecular biology 2002,315(5):1129–1143.PubMedCrossRef 64. White MF, Fothergill-Gilmore LA: Development of a mutagenesis, expression and purification system for yeast phosphoglycerate mutase. Investigation of the role of active-site His181. Eur J Biochem 1992,207(2):709–714.PubMedCrossRef

65. Geladopoulos TP, Sotiroudis TG, Evangelopoulos AE: A malachite selleck chemicals green colorimetric assay for protein phosphatase activity. Anal Biochem 1991,192(1):112–116.PubMedCrossRef 66. Kao FF, Mahmuda S, Pinto R, Triccas JA, West NP, Britton WJ: The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice. PloS one 2012,7(5):e34991.PubMedCentralPubMedCrossRef 67. Hedrick JL, Smith AJ: Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem Biophys 1968,126(1):155–164.PubMedCrossRef Competing interests We the authors hereby declare that there is no conflict of interest concerning this

manuscript. Authors’ contributions OOC, PP and SW conceived the study. OOC cloned Rv2135c and carried out the purification and biochemical characterization of the two enzymes. PS cloned Rv0489 and participated in the purification of the enzymes. KR and OOC determined the molecular masses of the purified enzymes. TP and SW supported the research. OOC and PP wrote the manuscript. selleck products PP coordinated and critically revised the manuscript. All authors read and approved the manuscript.”
“Background Enterococci are opportunistic pathogens of the normal intestinal microbiota of humans and animals [1, 2]. The most common species of Enterococcus involved in nosocomial infections is Enterococcus faecium (E. faecium) [1, 2]. This pathogen is associated with hospital-acquired infections such as UTIs (urinary tract infections), wounds, bacteremia, endocarditis and meningitis [1, 2]. In recent years, the emergence of multidrug-resistant E. faecium has increased [3–5]. The recommended treatment for Enterococcus infections

has been penicillin alone or combined with aminoglycosides. However, due to increased resistance to aminoglycosides, vancomycin is currently the antibiotic employed to treat these infections. In the last several decades, the number of vancomycin-resistant enterococci (VRE) has Bacterial neuraminidase increased. The first VRE isolates were reported in the United Kingdom in the late 1980s [6]. In the United States, more than 80% of E. faecium isolates from hospitals are now resistant to vancomycin, and virtually all of them (>90%) exhibit 5-Fluoracil datasheet ampicillin resistance [7]. Vancomycin-resistant Enterococcus faecium (VREF) has been associated with outbreaks in hospitals worldwide [2]. The rates of VREF colonization and infection have risen steadily, with most cases being caused by strains displaying glycopeptide resistance to VanA and VanB [8–11]. In addition to multidrug resistance, E.